EMA says no new patients should be started on Esyma for uterine fibroids

EMA says no new patients should be started on Esyma for uterine fibroids

February 13 2018 Doctors should not initiate Esyma (ulipristal acetate) in women with uterine...

New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

February 13 2018 The European Medicines Agency has issued new recommendations regarding use of...

EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

February 12 2018 The European Medicines Agency has updated advice regarding the use of retinoids...

New Drug Safety Update issued on need for contraception with mycophenolate mofetil

New Drug Safety Update issued on need for contraception with mycophenolate mofetil

February 9 2018 The medicines regulator has issued a Drug Safety Update relating to mycophenolate...

Study flags up concerns over antibiotic resistance in children's E coli in urinary infections

Study flags up concerns over antibiotic resistance in children's E coli in urinary infections

February 8 2018 Antibiotic resistance in children’s E. coli is high against many...

  • EMA says no new patients should be started on Esyma for uterine fibroids

    EMA says no new patients should be started on Esyma for uterine fibroids

    Tuesday, 13 February 2018 12:18
  • New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

    New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

    Tuesday, 13 February 2018 12:11
  • EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

    EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

    Monday, 12 February 2018 14:21
  • New Drug Safety Update issued on need for contraception with mycophenolate mofetil

    New Drug Safety Update issued on need for contraception with mycophenolate mofetil

    Friday, 09 February 2018 15:01
  • Study flags up concerns over antibiotic resistance in children's E coli in urinary infections

    Study flags up concerns over antibiotic resistance in children's E coli in urinary infections

    Thursday, 08 February 2018 10:39

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

APPROVEDFebruary 17 2016

 

 

The latest medicines approved for use by the Scottish Medicines Consortium are:

  • guanfacine hydrochloride (Intuniv) - for treating ADHD in children and adolescents 6-17 years old where stimulants are not useful, as part of a comprehensive ADHD treatment programme;
  • golimumab (Simponi) - for treating adults with severe, active nr-axSpA (axial spondyloarthritis) in certain circumstances and where NSAIDs are not useful;
  • panobinostat (Farydak) - for use in combination with bortezomib and dexamethasone in adults with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent;
  • ulipristal acetate (Esmya) - for the intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age;
  • fulvestrant (Faslodex) - for treating post-menopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant anti-oestrogen therapy, or disease progression on therapy with an anti-oestrogen.

In addition, the SMC has not recommended eculizumab (Soliris) for the treatment of adults and children with atypical haemolytic uraemic syndrome (aHUS)

Links:

SMC announcement

SMC February Briefing Note

Clinical News

  February 20 2018 A covert study of pharmacies has claimed that some pharmacies are failing to give adequate safety warnings when selling analgesics and cold remedies. The Consumer Association’s...
February 19 2018 Pharmacists should be receiving educational material this week on a new patient safety campaign from the Centre of Pharmacy Postgraduate Education. Resources have been mailed out ahead...